14 insiders reported 419 Form 4 transactions for CORCEPT THERAPEUTICS INC (CORT) over the past 18 months (most recent 2026-09-18). Recent activity: Robb Gary Charles (Chief Business Officer) Buy 17,493 shares, Vieira Roberto Wandenkolk (President, Oncology) Sell 296 shares, WILSON JAMES N (Director) Sell 6,800 shares, Lyon Joseph Douglas (Chief Accounting & Technology Officer) Buy 2,596 shares, WILSON JAMES N (Director) Sell 400 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-18 | Robb Gary Charles | Chief Business Officer | Buy | 17,493 | $144,667 |
| 2026-09-18 | Vieira Roberto Wandenkolk | President, Oncology | Sell | 296 | $29,843 |
| 2026-09-16 | WILSON JAMES N | Director | Sell | 6,800 | $749,835 |
| 2026-09-16 | Lyon Joseph Douglas | Chief Accounting & Technology Officer | Buy | 2,596 | $29,465 |
| 2026-09-16 | WILSON JAMES N | Director | Sell | 400 | $44,335 |
| 2026-09-16 | Lyon Joseph Douglas | Chief Accounting & Technology Officer | Buy | 7,404 | $100,398 |
| 2026-09-16 | WILSON JAMES N | Director | Sell | 2,800 | $312,771 |
| 2026-09-16 | Lyon Joseph Douglas | Chief Accounting & Technology Officer | Sell | 7,812 | $885,261 |
| 2026-09-16 | Lyon Joseph Douglas | Chief Accounting & Technology Officer | Sell | 2,188 | $249,686 |
| 2026-09-03 | Lyon Joseph Douglas | Chief Accounting & Technology Officer | Buy | 130 | $14,739 |
| 2026-09-03 | Mokari Atabak | Chief Financial Officer | Buy | 138 | $15,646 |
| 2026-09-03 | Maduck Sean | President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission | Buy | 25,000 | $206,750 |
| 2026-09-03 | Robb Gary Charles | Chief Business Officer | Buy | 164 | $18,594 |
| 2026-09-03 | Guyer William | Chief Development Officer | Buy | 164 | $18,594 |
| 2026-09-03 | Vieira Roberto Wandenkolk | President, Oncology | Buy | 138 | $15,646 |
| 2026-09-03 | Robb Gary Charles | Chief Business Officer | Buy | 164 | $0 |
| 2026-09-03 | Mokari Atabak | Chief Financial Officer | Buy | 138 | $0 |
| 2026-09-03 | Maduck Sean | President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission | Sell | 11,730 | $1.3M |
| 2026-09-03 | Lyon Joseph Douglas | Chief Accounting & Technology Officer | Buy | 130 | $0 |
| 2026-09-03 | Guyer William | Chief Development Officer | Buy | 164 | $0 |
| 2026-09-03 | Vieira Roberto Wandenkolk | President, Oncology | Buy | 138 | $0 |
| 2026-09-03 | Robb Gary Charles | Chief Business Officer | Sell | 91 | $10,318 |
| 2026-09-03 | Mokari Atabak | Chief Financial Officer | Sell | 102 | $11,565 |
| 2026-09-03 | Maduck Sean | President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission | Sell | 10,989 | $1.3M |
| 2026-09-03 | Lyon Joseph Douglas | Chief Accounting & Technology Officer | Sell | 72 | $8,163 |
Source: SEC Form 4 filings · as of 2026-09-18